Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 13.79
(0.95%)
CNY 13.79
(0.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.15 Billion CNY | -46.16% |
| 2022 | 7.53 Billion CNY | 50.56% |
| 2021 | 5 Billion CNY | 22.98% |
| 2020 | 4.07 Billion CNY | 49.77% |
| 2019 | 2.71 Billion CNY | 14.59% |
| 2018 | 2.37 Billion CNY | 41.85% |
| 2017 | 1.67 Billion CNY | 38.83% |
| 2016 | 1.2 Billion CNY | 92.78% |
| 2015 | 624.72 Million CNY | 28.2% |
| 2014 | 487.31 Million CNY | 29.32% |
| 2013 | 376.82 Million CNY | 49.37% |
| 2012 | 252.27 Million CNY | 49.93% |
| 2011 | 168.26 Million CNY | 36.83% |
| 2010 | 122.97 Million CNY | 32.11% |
| 2009 | 93.08 Million CNY | 76.95% |
| 2008 | 52.6 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 933.33 Million CNY | 24.61% |
| 2024 Q1 | 749.01 Million CNY | -4.22% |
| 2024 Q3 | 875.06 Million CNY | -6.24% |
| 2023 FY | 4.05 Billion CNY | -46.16% |
| 2023 Q3 | 1.1 Billion CNY | -6.35% |
| 2023 Q2 | 1.18 Billion CNY | 9.31% |
| 2023 Q4 | 781.99 Million CNY | -29.5% |
| 2023 Q1 | 1.08 Billion CNY | -2.28% |
| 2022 Q3 | 1.78 Billion CNY | -31.65% |
| 2022 Q1 | 2.04 Billion CNY | 45.76% |
| 2022 FY | 7.53 Billion CNY | 50.56% |
| 2022 Q4 | 1.1 Billion CNY | -37.7% |
| 2022 Q2 | 2.6 Billion CNY | 27.48% |
| 2021 FY | 5 Billion CNY | 22.98% |
| 2021 Q1 | 1.09 Billion CNY | -14.4% |
| 2021 Q4 | 1.4 Billion CNY | -6.13% |
| 2021 Q3 | 1.49 Billion CNY | 46.34% |
| 2021 Q2 | 1.02 Billion CNY | -6.43% |
| 2020 Q2 | 1.2 Billion CNY | 172.22% |
| 2020 Q4 | 1.27 Billion CNY | 11.45% |
| 2020 FY | 4.07 Billion CNY | 49.77% |
| 2020 Q3 | 1.14 Billion CNY | -5.49% |
| 2020 Q1 | 444.26 Million CNY | -37.69% |
| 2019 Q4 | 713 Million CNY | 3.37% |
| 2019 FY | 2.71 Billion CNY | 14.59% |
| 2019 Q1 | 569.38 Million CNY | -22.14% |
| 2019 Q2 | 745.63 Million CNY | 30.95% |
| 2019 Q3 | 689.78 Million CNY | -7.49% |
| 2018 Q2 | 602.41 Million CNY | 54.69% |
| 2018 Q1 | 389.42 Million CNY | -8.99% |
| 2018 Q3 | 648.6 Million CNY | 7.67% |
| 2018 Q4 | 731.31 Million CNY | 12.75% |
| 2018 FY | 2.37 Billion CNY | 41.85% |
| 2017 Q1 | 333.7 Million CNY | -13.8% |
| 2017 Q3 | 463.97 Million CNY | 3.94% |
| 2017 Q4 | 427.91 Million CNY | -7.77% |
| 2017 FY | 1.67 Billion CNY | 38.83% |
| 2017 Q2 | 446.38 Million CNY | 33.76% |
| 2016 FY | 1.2 Billion CNY | 92.78% |
| 2016 Q4 | 387.14 Million CNY | 29.55% |
| 2016 Q3 | 298.83 Million CNY | -10.13% |
| 2016 Q2 | 332.5 Million CNY | 78.89% |
| 2016 Q1 | 185.86 Million CNY | 11.95% |
| 2015 Q3 | 162.26 Million CNY | -12.01% |
| 2015 Q4 | 166.03 Million CNY | 2.32% |
| 2015 Q1 | 112 Million CNY | -8.53% |
| 2015 FY | 624.72 Million CNY | 28.2% |
| 2015 Q2 | 184.4 Million CNY | 64.64% |
| 2014 Q3 | 129.89 Million CNY | -10.08% |
| 2014 FY | 487.31 Million CNY | 29.32% |
| 2014 Q1 | 90.51 Million CNY | -11.18% |
| 2014 Q2 | 144.45 Million CNY | 59.6% |
| 2014 Q4 | 122.45 Million CNY | -5.72% |
| 2013 Q4 | 101.9 Million CNY | 3.25% |
| 2013 FY | 376.82 Million CNY | 49.37% |
| 2013 Q1 | 66.26 Million CNY | -14.25% |
| 2013 Q2 | 109.96 Million CNY | 65.96% |
| 2013 Q3 | 98.69 Million CNY | -10.25% |
| 2012 Q2 | 69.15 Million CNY | 56.43% |
| 2012 Q4 | 77.27 Million CNY | 25.35% |
| 2012 Q3 | 61.64 Million CNY | -10.86% |
| 2012 Q1 | 44.2 Million CNY | -15.57% |
| 2012 FY | 252.27 Million CNY | 49.93% |
| 2011 Q4 | 52.35 Million CNY | 37.26% |
| 2011 FY | 168.26 Million CNY | 36.83% |
| 2011 Q2 | 47.33 Million CNY | 55.59% |
| 2011 Q1 | 30.42 Million CNY | -10.44% |
| 2011 Q3 | 38.14 Million CNY | -19.41% |
| 2010 Q1 | 23.06 Million CNY | 0.0% |
| 2010 Q4 | 33.96 Million CNY | 5.37% |
| 2010 Q3 | 32.23 Million CNY | -4.35% |
| 2010 Q2 | 33.7 Million CNY | 46.16% |
| 2010 FY | 122.97 Million CNY | 32.11% |
| 2009 FY | 93.08 Million CNY | 76.95% |
| 2008 FY | 52.6 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 2.72 Billion CNY | -52.515% |
| Dirui Industrial Co.,Ltd. | 669.29 Million CNY | -520.369% |
| Beijing Strong Biotechnologies, Inc. | 1.3 Billion CNY | -219.304% |
| Medicalsystem Biotechnology Co., Ltd. | 834.37 Million CNY | -397.633% |
| Maccura Biotechnology Co.Ltd | 1.51 Billion CNY | -174.691% |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.72 Billion CNY | -140.769% |
| Guangdong Hybribio Biotech Co.,Ltd. | 662.35 Million CNY | -526.875% |
| BGI Genomics Co., Ltd. | 2.17 Billion CNY | -91.289% |
| Amoy Diagnostics Co., Ltd. | 871.54 Million CNY | -376.412% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 329.31 Million CNY | -1160.839% |